Rigid crosslinking of the CD3 complex leads to superior T cell stimulation.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 17 05 2024
accepted: 07 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

Functionally bivalent non-covalent Fab dimers (Bi-Fabs) specific for the TCR/CD3 complex promote CD3 signaling on T cells. While comparing functional responses to stimulation with Bi-Fab, F(ab')2 or mAb specific for the same CD3 epitope, we observed fratricide requiring anti-CD3 bridging of adjacent T cells. Surprisingly, anti-CD3 Bi-Fab ranked first in fratricide potency, followed by anti-CD3 F(ab')2 and anti-CD3 mAb. Low resolution structural studies revealed anti-CD3 Bi-Fabs and F(ab')2 adopt similar global shapes with CD3-binding sites oriented outward. However, under molecular dynamic simulations, anti-CD3 Bi-Fabs crosslinked CD3 more rigidly than F(ab')2. Furthermore, molecular modelling of Bi-Fab and F(ab')2 binding to CD3 predicted crosslinking of T cell antigen receptors located in opposing plasma membrane domains, a feature fitting with T cell fratricide observed. Thus, increasing rigidity of Fab-CD3 crosslinking between opposing effector-target pairs may result in stronger T cell effector function. These findings could guide improving clinical performance of bi-specific anti-CD3 drugs.

Identifiants

pubmed: 39281668
doi: 10.3389/fimmu.2024.1434463
pmc: PMC11392757
doi:

Substances chimiques

CD3 Complex 0
Immunoglobulin Fab Fragments 0
Receptors, Antigen, T-Cell 0
Receptor-CD3 Complex, Antigen, T-Cell 0
Antibodies, Monoclonal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1434463

Informations de copyright

Copyright © 2024 Nelson, Wang, Laffey, Becher, Parks, Hoffmann, Galeano, Mangalam, Teixeiro, White, Schrum, Cannon and Gil.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Alfreda D Nelson (AD)

Department of Surgery, School of Medicine, University of Missouri, Columbia, MO, United States.

Liangyu Wang (L)

Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.

Kimberly G Laffey (KG)

Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.

Laura R E Becher (LRE)

Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Christopher A Parks (CA)

Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Michele M Hoffmann (MM)

Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Belinda K Galeano (BK)

Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN, United States.

Ashutosh Mangalam (A)

Department of Pathology, University of Iowa, Iowa City, IA, United States.

Emma Teixeiro (E)

Department of Surgery, School of Medicine, University of Missouri, Columbia, MO, United States.
Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.

Tommi A White (TA)

Department of Biochemistry, University of Missouri, Columbia, MO, United States.

Adam G Schrum (AG)

Department of Surgery, School of Medicine, University of Missouri, Columbia, MO, United States.
Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.
Department of Biomedical, Biological and Medical Engineering, College of Engineering, University of Missouri, Columbia, MO, United States.

John F Cannon (JF)

Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.

Diana Gil (D)

Department of Surgery, School of Medicine, University of Missouri, Columbia, MO, United States.
Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, United States.
Department of Biomedical, Biological and Medical Engineering, College of Engineering, University of Missouri, Columbia, MO, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH